Are there specific anatomical and/or transmitter systems (cortical or subcortical) that should be targeted?
Jobe
Phillip C
PC
Department of Biomedical and Therapeutic Sciences, University of Illinois College of Medicine at Peoria, Peoria, Illinois 61656, USA.
D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use*; D001933:Brain Stem / Q000503:physiopathology*; D004569:Electroencephalography; D006801:Humans; D007223:Infant; D009434:Neural Pathways / Q000503:physiopathology; D018377:Neurotransmitter Agents / Q000502:physiology*; D016548:Prosencephalon / Q000503:physiopathology*; D012640:Seizures / Q000188:drug therapy / Q000503:physiopathology; D013036:Spasms, Infantile / Q000188:drug therapy* / Q000503:physiopathology* / Q000523:psychology
D000927:Anticonvulsants; D018377:Neurotransmitter Agents